Disordered Toll-like receptor 2 responses in the pathogenesis of pulmonary sarcoidosis

Clinical and Experimental Immunology

Volumn 173, Issue 3, 2013, Pages 512-522

  Gabrilovich, M I ^a,c   Walrath, J ^a,b,d   Van Lunteren, J ^a,d   Nethery, D ^a   Seifu, M ^a,c   Kern, J A ^a,c,d,f   Harding, C V ^a   Tuscano, L ^a,d   Lee, H ^a,d   Williams, S D ^a,e   Mackay, W ^b   Tomashefski, J F ^a,e   Silver, R F ^a,b,c,d  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Infectious Diseases Section   (United States)

^c UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^d LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

^e METROHEALTH MEDICAL CENTER   (United States)

^f DEPARTMENT OF MEDICINE   (United States)

Author keywords

Bronchoalveolar lavage (BAL); Sarcoidosis; Toll like receptors

Indexed keywords

INTERLEUKIN 6; LIPOPEPTIDE; LIPOPROTEIN; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL COMPOSITION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; FEMALE; FLOW CYTOMETRY; GENE DELETION; GENE DISRUPTION; GRANULOMATOUS INFLAMMATION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LUNG ALVEOLUS CELL; LUNG ALVEOLUS MACROPHAGE; LUNG HOMOGENATE; LUNG LAVAGE; LUNG SARCOIDOSIS; LYMPHOCYTOSIS; MALE; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PATHOGENESIS; PNEUMONIA; PRIORITY JOURNAL; PROPIONIBACTERIUM ACNES; SENSITIZATION; TH1 CELL;

BRONCHOALVEOLAR LAVAGE (BAL); SARCOIDOSIS; TOLL-LIKE RECEPTORS;

ADOLESCENT; ADULT; AGED; ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; CASE-CONTROL STUDIES; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION; HUMANS; LIGANDS; MALE; MICE; MICE, KNOCKOUT; MIDDLE AGED; PNEUMONIA; PROPIONIBACTERIUM ACNES; PROTEIN MULTIMERIZATION; SARCOIDOSIS, PULMONARY; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTORS; YOUNG ADULT;

EID: 84881496773     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/cei.12138     Document Type: Article

References (41)

1. Zissel G, Prasse A, Muller-Quernheim J. Immunologic response of sarcoidosis. Semin Respir Crit Care Med 2010; 321:390-403.
2. Saboor SA, Johnson NM, McFadden J. Detection of mycobacterial DNA in sarcoidosis and tuberculosis with polymerase chain reaction. Lancet 1992; 339:1012-1015.
3. Almenoff PL, Johnson A, Lesser M, Mattman LH. Growth of acid fast L forms from the blood of patients with sarcoidosis. Thorax 1996; 51:530-533.
4. Drake WP, Pei Z, Pride DT, Collins RD, Cover TL, Blaser MJ. Molecular analysis of sarcoidosis tissues for mycobacterium species DNA. Emerg Infect Dis 2002; 11:1334-1341.
5. Song Z, Marzilli L, Greenlee BM etal. Mycobacterial catalase-peroxidase is a tissue antigen and target of the adaptive immune response in systemic sarcoidosis. J Exp Med 2005; 201:755-767.
6. Oswald-Richter KA, Culver DA, Hawkins C etal. Cellular responses to mycobacterial antigens are present in bronchoalveolar lavage fluid used in the diagnosis of sarcoidosis. Infect Immun 2009; 77:3740-3748.
7. Ebe Y, Ikushima S, Yamaguchi T etal. Proliferative response of peripheral blood mononuclear cells and levels of antibody to recombinant protein from Propionibacterium acnes DNA expression library in Japanese patients with sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2000; 17:256-265.
8. Yamada T, Eishi Y, Ikeda S etal. In situ localization of Propionibacterium acnes DNA in lymph nodes from sarcoidosis patients by signal amplification with catalysed reporter deposition. J Pathol 2002; 198:541-547.
9. Bocart D, Lecossier D, De Lassence A, Valelyre D, Battesti J, Hance AJ. A search for mycobacterial DNA in granulomatous tissues from patients with sarcoidosis using the polymerase chain reaction. Am Rev Respir Dis 1992; 145:1142-1148.
10. Brown ST, Brett I, Almenoff PL, Lesser M, Terrin M, Teirstein AS. Recovery of cell wall-deficient organisms from blood does not distinguish between patients with sarcoidosis and control subjects. Chest 2003; 123:413-417.
11. Ishige I, Eishi Y, Takemura T etal. Propionibacterium acnes is the most common bacterium commensal in peripheral lung tissue and mediastinal lymph nodes from subjects without sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2005; 22:33-42.
12. Basu S, Fenton M. Toll-like receptors: function and roles in lung disease. Am J Physiol Lung Cell Mol Physiol 2004; 286:L887-892.
13. Ishioka S, Saito T, Hiyama K etal. Increased expression of tumor necrosis factor-alpha, interleukin-6, platelet-derived growth factor B and granulocyte-macrophage colony stimulating factor mRNA in cells of bronchoalveolar lavage fluides from patients with sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 1996; 13:139-145.
14. McCaskill JG, Chason KD, Hua X etal. Pulmonary immune responses to Propionibacterium acnes in C57BL/6 and BALB/c mice. Am J Respir Cell Mol Biol 2006; 35:347-356.
15. Silver RF, Li Q, Zukowski L etal. Recruitment of antigen-specific Th1-like responses to the human lung following segmental antigen challenge with purified protein derivative of M.tuberculosis. Am J Respir Cell Mol Biol 2003; 29:117-123.
16. Drage MG, Pecora ND, Hise AG etal. TLR2 and its co-receptors determine responses of macrophages and dendritic cells to liproproteins of Mycobacterium tuberculosis. Cell Immunol 2009; 258:29-37.
17. Takeuchi O, Hoshino K, Kawai T etal. Differential roles of TLR2 and TLR4 in recognition of Gram-negative and Gram-positive bacterial cell wall components. Immunity 1999; 11:443-451.
18. Nethery DE, Moore BB, Minowada G, Carroll J, Faress JA, Kern JA. Expression of mutant human epidermal receptor 3 attenuates lung fibrosis and improves survival in mice. J Appl Physiol 2005; 99:298-307.
19. Kutchey J, Fulton SA, Reba SM, Harding CV, Boom WH. Interferon-αβ mediates partial control of early pulmonary Mycobacterium bovis bacillus Calmette-Guérin infection. Immunology 2006; 118:39-49.
20. Okusawa T, Fujita M, Nakamura J etal. Relationship between structures and biological activities of mycoplasmal diacylated lipopeptides and their recognition by Toll-like receptors 2 and 6. Infect Immun 2004; 72:1657-1665.
21. Pabst S, Baumgarten G, Stremmel A etal. Toll-like receptor (TLR) 4 polymorphisms are associated with a chronic course of sarcoidosis. Clin Exp Immunol 2006; 143:420-426.
22. Veltkamp M, Grutters JC, van Moorsel CH, Ruven HJ, van den Bosch JM. Toll-like receptor (TLR) 4 polymorphism Asp299Gly is not associated with disease course in Dutch sarcoidosis patients. Clin Exp Immunol 2006; 145:215-218.
23. Sato M, Kawagoe T, Meguro A etal. Toll-like receptor 2 (TLR2) gene polymorphisms are not associated with sarcoidosis in the Japanese population. Mol Vis 2011; 17:731-736.
24. Veltkamp M, Wijnen PA, van Moorsel CH etal. Linkage between Toll-like receptor (TLR) 2 promotor and intron polymorphisms: functional effects and relevance to sarcoidosis. Clin Exp Immunol 2007; 149:453-462.
25. Veltkamp M, van Moorsel CHM, Rijkers GT, Ruven HJT, Grutters JC. Genetic variation in the Toll-like receptor gene cluster (TLR10-TLR1-TLR6) influences disease course in sarcoidosis. Tissue Antigens 2011; 79:25-32.
26. Wennerstrom A, Pietinalho A, Vaukonen H etal. HLA-DRB1 allele frequencies and C4 copy number variation in Finnish sarcoidosis patients and association with disease prognosis. Hum Immunol 2012; 73:93-100.
27. Howson JMM, Roy MS, Stevens H, Todd JA. HLA class II gene associations in African American Type 1 diabetes reveal a protective HLA-DRB1*03 haplotype. Diabet Med 2013; 6:710-716.
28. Chen ES, Song Z, Willett MH etal. Serum amyloid A regulates granulomatous inflammation in sarcoidosis through Toll-like receptor-2. Am J Respir Crit Care Med 2010; 181:360-373.
29. Szebeni B, Veres G, Dezsofi A etal. Increased expression of Toll-like receptor (TLR)-2 and TLR-4 in the colonic mucosa of children with inflammatory bowel disease. Clin Exp Immunol 2008; 151:34-41.
30. Hopkins PA, Pridmore AC, Ellmerich S etal. Increased surface Toll-like receptor 2 expression in superantigen shock. Crit Care Med 2008; 36:1267-1276.
31. Homolka J, Muller-Quernheim J. Increased interleukin 6 production by bronchoalveolar lavage cells in patients with active sarcoidosis. Lung 1993; 171:173-183.
32. Pueringer RJ, Schwartz DA, Dayton CS, Gilbert SR, Hunninghake GW. The relationship between alveolar macrophage TNF, IL-1, and PGE2 release, alveolitis, and disease severity in sarcoidosis. Chest 1993; 103:832-838.
33. Shigehara K, Shijubo N, Ohmichi M etal. IL-12 and IL-18 are increased and stimulate IFN-gamma production in sarcoid lungs. J Immunol 2001; 166:642-649.
34. Turner JD, Langley RS, Johnston KL, Egerton G, Wanji S, Taylor MJ. Wolbachia endosymbiotic bacteria of Brugia malayi mediate macrophage tolerance to TLR- and CD40-specific stimuli in a MyD88/TLR2-dependent manner. J Immunol 2006; 177:1240-1249.
35. Kawamoto T, Ii M, Kitazaki T, Iizawa Y, Kimura H. TAK-242 selectively suppresses Toll-like receptor 4-signaling mediated by the intracellular domain. Eur J Pharmacol 2008; 584:40-48.
36. Laplante P, Amireault P, Subang R, Dieudé M, Levine JS, Rauch J. Interaction of β2-glycoprotein I with lipopolysaccharide leads to Toll-like receptor 4 (TLR4)-dependent activation of macrophages. J Biol Chem 2011; 286:42494-42503.
37. Kelly DM, Greene CM, Meachery G etal. Endotoxin up-regulates interleukin-18: potential role for Gram-negative colonization in sarcoidosis. Am J Respir Crit Care Med 2005; 172:1299-1307.
38. Buwitt-Beckmann U, Heine H, Weismuller K-H, Jung G, Brock R, Ulmer AJ. Lipopeptide structure determines TLR2-dependent cell activation level. FEBS J 2005; 272:6354-6364.
39. Strunk T, Power Coombs MR, Currie AJ etal. TLR2 mediates recognition of live Staphylococcus epidermidis and clearance of bacteremia. PLoS ONE 2010; 9:e10111.
40. Kim J, Ochoa MT, Krutzik SR etal. Activation of Toll-like receptor 2 in acne triggers inflammatory cytokine responses. J Immunol 2002; 169:1535-1541.
41. Kalis C, Gumenscheimer M, Freudenberg N etal. Requirement for TLR9 in the immunomodulatory activity of Propionibacterium acnes. J Immunol 2005; 174:4295-4300.